BridgeMD
New treatment option for Cerebral Palsy
Official title Assessment of Navigation Abilities in Children With Cerebral Palsy and Their Peers
ClinicalTrials.gov ID: NCT06320106
What this study is testing
- What it's testing
- Spatial navigation skills are very important in everyday activities and quality of life but spatial navigation abilities are not part of the standard process of assessment and rehabilitation of patients. Furthermore, it is known that children with cerebral palsy have impaired visuo-spatial competences.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 and older. Healthy volunteers may be eligible.
You may be able to join if
- IQ higher than 70
You likely can't join if
- people with epileptic issues
- people with poor head control
- Visual acuity not correctable with eyeglasses
The study team makes the final eligibility decision.
Where it's taking place
- Bosisio Parini, Lecco, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bosisio Parini, Lecco, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.